Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
The IXP Lifesciences Catalyst Fund has a greenshoe option of Rs 100 crore with an investment horizon of 3-5 years targeting ...
It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US counterparts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback